Complete Analytical Testing Solutions
Tailored To Your Needs
GA Labs is committed to provide companies the security of knowing that their products are continuously monitored for precision, correct composition, safety and compliance.
The acronym ALCOA requires data to be attributable, legible, contemporaneous, original, and accurate. The acronym ALCOA+ adds the concepts that, in addition to ALCOA, data also needs to be complete, consistent, enduring, and available. UAL practise the implementation of the ALCOA+ principle to attain data integrity standards.
GA Labs is committed to provide timely data with accuracy and help partners avoid any negative outcomes that may arise due to irregular timelines.
Method Development, Method Validation, Method Verification and Method Transfer protocols have all been designed and executed by our laboratory staff.
Method Development and Validation studies are critical to your product’s success. It’s critical to have a dedicated and committed entity on your side. Robust, well-developed analytical procedures save the sponsor money in the long term by protecting the products against out-of-spec or out-of-trend outcomes during release specification testing.
ICH Q6A indicates that ‘the quality of drug substances and drug products is determined by their design, development, in-process controls, GMP controls, and process validation, and by specifications applied to them throughout development and manufacture’. GA Labs is committed to follow and standardise quality aspects to meet those standards.